1Konya J, Dillner J. Immunity to oncogenic human papillomavirus[J]. Adv Cancer Res, 2001,82:205 - 238.
2Kobayashi A, Miaskowski C, Wallhagen M, et al. Recent development in understanding the immune response to human papillomavirus infection and cervical neoplasia[J]. Oncol Nurs Forum, 2000,27(4) :643 - 651.
3Scott M, Stites DP, Moscicki AB. Th1 cytokine patterns in cervical human papillomavirus infection[J]. Clin Diagn Lab Immunol, 1999,6(5) :751 - 755.
4Connor JP, Terrer K, Kane JP, et al. Evaluation of langerhans cells in the cervical epithelium of women with cervical intraepithelial neoplasia[J ]. Gynecol Oncol, 1999,75( 1 ) : 130 - 135.
5Lakatosh VP, Stechenko LO, Kuftyrova TP, et al. The characteristic of the ultrastructural organization of the cervical uterimucosa after the combined treatment of a papillomavirus infection[J]. Lik Sorave. 2000.2:100- 103.
6Evans M, Borysiewicz LK, Evans AS, et al. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirusl6 E6[J]. J Immunol, 2001.167(9) :5420 - 5428.
7Trizna Z, Evans T, Bruce S, et al. A randomized phase Ⅱ study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata[J]. Sex Transm Dis,1998,25(7) :361 - 365.
8Lozada NF, Glick M, Schubert M, et al. Use of intralesional interferon-alpha for the treatment of recalcitrant oral warts in patients with AIDS[J ]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001,92(6) :617 - 622.
9Syed TA, Ahmadpour OA. Human leukocyte interferon-alpha in a hydrophilic gel for the treament of intravaginal warts in women : a placebo-controlled double-blind study[J]. Int J STD AIDS, 1998,9(12) :769 - 772.
10Palomba M, Melis GB. Oral use of interferon therapy in cervical human papillomavirus infection[J]. Clin Ter, 2000, 151( 1Supple 1 ) : 59 - 61.
3[3]Gross G,Rogozinski T,Schofer H,et al.Recombinant interferon bera gel as an adjuvant in the treatment of a recurrent genital warts:results of a placebo-controlled double-blind study in 120 patients[J].Dermatology,1998,196:330-334.
